Halozyme Therapeutics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amarin USD 36.57M 397K 2025-03
Amgen USD 1.69B 4M 2025-06
Baxter International USD 718M 15M 2025-06
Cytokinetics USD 65.72M 8.35M 2025-06
DBV Technologies USD 4.31M 685K 2025-03
Eli Lilly USD 2.75B 390.8M 2025-06
Halozyme Therapeutics USD 33M 9.36M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
MannKind USD 31.62M 6.61M 2025-06
Pfizer USD 3.42B 406M 2025-06
United Therapeutics USD 212.5M 42.4M 2025-06


Halozyme Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.